PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINING SINGLE-TABLET REGIMEN (D/C/F/TAF) COMPARED WITH OTHER MULTI-TABLET REGIMENS CONTAINING BOOSTED PROTEASE INHIBITORS (BPIS)
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1380
https://www.valueinhealthjournal.com/article/S1098-3015(18)34682-5/fulltext
Title :
PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINING SINGLE-TABLET REGIMEN (D/C/F/TAF) COMPARED WITH OTHER MULTI-TABLET REGIMENS CONTAINING BOOSTED PROTEASE INHIBITORS (BPIS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34682-5&doi=10.1016/j.jval.2018.09.1380
First page :
Section Title :
Open access? :
No
Section Order :
764